Seeking Alpha

Shares of Sequenom (SQNM +11.1%) pop after the company announces the launch of its MaterniT21...

Shares of Sequenom (SQNM +11.1%) pop after the company announces the launch of its MaterniT21 noninvasive prematernal test for Down syndrome. The test is now available in 20 metropolitan cities for expectant women.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector